M Lloyd Jones

1.5k total citations · 1 hit paper
12 papers, 1.3k citations indexed

About

M Lloyd Jones is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, M Lloyd Jones has authored 12 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 3 papers in Surgery and 3 papers in General Health Professions. Recurrent topics in M Lloyd Jones's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). M Lloyd Jones is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). M Lloyd Jones collaborates with scholars based in United Kingdom. M Lloyd Jones's co-authors include Jeremy Wight, Roberta Ara, M Holmes, W W Yeo, Sue Ward, Abdullah Pandor, Nick Payne, J. Chilcott, Matt Stevenson and N. Calvert and has published in prestigious journals such as Health Technology Assessment and Haemophilia.

In The Last Decade

M Lloyd Jones

12 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A systematic review and economic evaluation of statins for the prevention of coronary events

2007 452 citations Sue Ward, M Lloyd Jones et al. Health Technology Assessment profile →

Peers

Countries citing papers authored by M Lloyd Jones

Since Specialization

Citations

This map shows the geographic impact of M Lloyd Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Lloyd Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Lloyd Jones more than expected).

Fields of papers citing papers by M Lloyd Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Lloyd Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Lloyd Jones. The network helps show where M Lloyd Jones may publish in the future.

Co-authorship network of co-authors of M Lloyd Jones

This figure shows the co-authorship network connecting the top 25 collaborators of M Lloyd Jones. A scholar is included among the top collaborators of M Lloyd Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Lloyd Jones. M Lloyd Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature 2012 ·Health Technology Assessment ·Carolyn Czoski‐Murray, M Lloyd Jones, Colm McCabe, K Claxton, Yemi Oluboyede, Jonathan Roberts, JP Nicholl, Alan Rees, CS Reilly, Duncan Young, T Fleming	123
2	Survey of current practice on pre-operative testing in ASA grade 1 and ASA grade 2 2012 ·Carolyn Czoski‐Murray, M Lloyd Jones, Christopher McCabe, K Claxton, Yemi Oluboyede, J. R. Roberts, JP Nicholl, A Rees, CS Reilly, (unknown), Thomas R. Fleming	1
3	School-linked sexual health services for young people (SSHYP): a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities 2010 ·Health Technology Assessment ·Jenny Owen, Christopher Carroll, Jo Cooke, Eleanor Formby, Mark Hayter, Julia Hirst, M Lloyd Jones, Helen Stapleton, Moire Stevenson, Anthea Sutton	84
4	Docetaxel for the adjuvant treatment of early nodepositive breast cancer: a single technology appraisal 2009 ·Health Technology Assessment ·J. Chilcott, M Lloyd Jones, Anne Wilkinson	47
5	Docetaxel for the adjuvant treatment of early nodepositive breast cancer: a single technology appraisal 2009 ·Health Technology Assessment ·J. Chilcott, M Lloyd Jones, Anne Wilkinson	5
6	A systematic review and economic evaluation of statins for the prevention of coronary events breakdown → 2007 ·Health Technology Assessment ·Sue Ward, M Lloyd Jones, Abdullah Pandor, M Holmes, Roberta Ara, (unknown), W W Yeo, Nick Payne	452
7	Control of bleeding in patients with haemophilia A with inhibitors: a systematic review 2003 ·Haemophilia ·M Lloyd Jones, Jeremy Wight, Suzy Paisley, Carl Knight	70
8	Economic modelling of different treatment strategies for haemophilia A with high‐responding inhibitors 2003 ·Haemophilia ·Carl Knight, Suzy Paisley, Jeremy Wight, M Lloyd Jones	61
9	A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative 2003 ·Health Technology Assessment ·J. Chilcott, M Lloyd Jones, Jeremy Wight, (unknown), Julie Wray, Catherine Beverley, Paul Tappenden	174
10	A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. 2002 ·Health Technology Assessment ·M Lloyd Jones, S Hummel, Nick Bansback, (unknown), Michel Seymour	38
11	Treatment of established osteoporosis: a systematic review and cost-utility analysis 2002 ·Health Technology Assessment ·John А. Kanis, John Brazier, Matt Stevenson, N. Calvert, M Lloyd Jones	200
12	The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review 2001 ·Health Technology Assessment ·J. Chilcott, Jeremy Wight, M Lloyd Jones, Paul Tappenden	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact